15th Dec 2005 17:34
GlaxoSmithKline PLC15 December 2005 I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 12 December 2005 Abacus Corporate Trustee Limited, as trustee of the GlaxoSmithKline (US) Trust, ("the GSK US Trust"), sold 1,972 ADR Shares in the Company to participants in the GlaxoSmithKline Restricted Share Plan at a price of $50.99 per ADR share. Abacus Corporate Trustee Limited, as trustee of the GSK US Trust, transferred 4,093 ADR Shares to participants in the GlaxoSmithKline Restricted Share Plan. The Company was advised of these transactions on 15 December 2005. The GSK US Trust is a grantor trust of which all employees or former employeesof SmithKline Beecham Corporation and its subsidiaries are potentialbeneficiaries. Two of the Company's directors, Dr J-P Garnier and Dr T Yamadaare therefore interested in the shares held in the GSK US Trust from time totime in the same way as other employees or former employees of SmithKlineBeecham Corporation and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 15 December 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline